Hedge Funds Are Selling SAGE Therapeutics Inc (SAGE)
A whopping number of 13F filings filed with U.S.
Sage Therapeutics Inc. (SAGE)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
Three Biotech Investment Ideas from Cormorant Asset Management
The biotech industry is regaining ground it lost in 2016 at full speed.
Zogenix Inc. (ZGNX) and Arena Pharmaceuticals, Inc. (ARNA) Helped This Healthcare-Focused Fund Earn Double-Digit Returns
It's no secret that hedge funds have been underperforming the market by quite a wide margin in the last couple of years.
10 Biggest Antidepressant Drug Companies In 2017
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide.
Amid The Perceived Gloom In The Hedge Fund Universe, This Hedge Fund's Stock Picks Gained 38.8% in Q1
The dismal performance, redemptions and shuttering of some hedge funds have received significant media attention in the past two years.
Look: Sage Therapeutics (SAGE) breaks into new 52-week high
The biopharmaceutical company with a $2.74 billion market cap played around $69.50 to $73.60 on the trading charts, before it closed to $73.44. Most recently, Sage Therapeutics Inc.
5 Stocks The Best Performing Hedge Funds Are Piling Into
At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we collect from their 13F filings...
Positive Results For MDD Drug Sends Shares Of SAGE Therapeutics Inc (SAGE) Soaring
Shares of SAGE Therapeutics Inc (NASDAQ:SAGE) surged after the results of a small, mid-stage study on major depressive disorder showed positive results.
How SAGE Therapeutics Inc (SAGE) Stacks Up Against Its Peers
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
SAGE Therapeutics Inc (SAGE): What Just Happened, And What's Next?
SAGE Therapeutics Inc (NASDAQ:SAGE) is running up on a trial update this week, with the company currently trading a little over 12% higher than its close on Friday.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
